Novocure Secures FDA Approval for Add-ons to Brain Cancer Treatment Wearable
NovoCure's Buy Rating Backed by FDA Approval and Strategic Growth Plans Amidst Potential Risks
The FDA Approves Novocure's New Head Flexible Electrode Transducer Arrays For Use With Optune Gio For Adult Patients With Glioblastoma Multiforme, Novocure Plans To Convert Optune Gio Users In The U.S. To The New HFE Arrays Through The First Half Of...
Express News | Novocure Ltd - to Convert Optune Gio Users to New Hfe Arrays by Mid-2025
Express News | FDA Approves Novocure’s Innovative Hfe Transducer Arrays for Use With Optune Gio® for Glioblastoma
Analysts Conflicted on These Healthcare Names: Penumbra (PEN), Kymera Therapeutics (KYMR) and NovoCure (NVCR)